1. Chromium sesquioxide (Cr,O,; 1.5 g/day) and [slCr]chromic chloride [ WrCl, (0.3 pCi/day)l were compared as continuously administered non-absorbed markers for the correction of faecal recoveries in 14 calcium balance studies each lasting at least 18 days.
Introduction
Chromium sesquioxide (Cr,O,) is widely used as a non-absorbable marker in metabolic balance studies to correct for incomplete recovery of faeces and variations in intestinal transit times. Since the estimation of chromium in faeces has been associated with the risk of explosions, which can Correspondence: Mr R. Hesp, Radioisotopes Division, MRC Clinical Research Centre, Watford Road, Harrow, Middlesex HA1 3UJ, U.K. only be eliminated at some cost and inconvenience, we decided to investigate the use of T r C l , as an alternative to Cr,O,. Both markers were therefore given in 14 studies, each of which included three or more 4-or 6-day faecal collections. Thus we were able to make a comparison between the two markers to assess their relative merits.
Patients and methods
In the course of conducting calcium balance studies, continuous 18-day complete stool collections were made on each of 12 female patients with osteoporosis. None had diarrhoea. Two patients were studied twice. A 6-day equilibration period, during which both markers were given, preceded the collection periods in every case. In most studies the collections were divided into three 6-day pools but, in the two repeat studies, respectively six and seven 4-day pools were obtained. The balance diets were designed to approximate closely each patient's daily intake of calcium and magnesium. The procedure used has been previously described in detail (Reeve, Tregear & Parsons, 1976) .
Each patient received 0.5 g of Cr,O, orally, together with a gelatin capsule containing 0-1 pCi of 51CrC13, 1.0 mg of CrCl, carrier and 500 mg of lactose, three times per day with meals throughout the equilibration and study periods. Thus the total intake of W r was normally 7.2 pCi for each patient (i.e. 0.3 pCi x 24 days) giving a total radiation dose to the gastrointestinal tract of about 36 mrads, assuming a gut transit time of 2 days (I.C.R.P., 1971).
Some patients with a previously noted tendency to constipation were prophylactically given 2-5 g of Isogel (Allen and Hanburys Ltd) daily, in divided doses with meals, from the start of their study. Stool collection and intake of the two markers ceased simultaneously at the end of each study.
Each 6-day collection was transferred to a sample container (external dimensions 15 cm diameter x 16 cm high) and homogenized after addition of an approximately equal volume of distilled water. The "Cr (0.32 MeV gamma rays, half-life 28 days) content of each bulk stool sample was measured with a low-background shielded counter, similar to that described by Cronquist, MacKenzie & Smith (1973, which incorporated two vertically opposed NaI (Tl) crystals (10 cm diameter x 7.5 cm thick) with faces 40 cm apart. The sample container was placed on a Perspex platform which was equidistant from both crystals. The radioactivity count rates from the two crystals were added and the gamma-ray spectrum was recorded by means of a multichannel analyser. A portion of the "Cr dose (1 pCi, approximate volume 10 ml) was used as reference standard, and placed on the centre of the Perspex platform for counting.
Calibration curves, which permit corrections to be made for the weight of sample, are shown in Fig.  1 for the photopeak (0-27-0.37 MeV) and a wide band (0.104.37 MeV). Background and counting sensitivities were approximately 1 . 1 counts/s, and 90 counts s-l ,uCi-' for the photopeak, and 3.3 counts/s and 120 counts s-' PCi-' for the wide energy band. For the latter, the SE for counting the standard (counting times 1000 s each for standard and background) was 0.34%, with a similar SE of 0.34% for the sample, and a SE of & 0.5% for the weight correction factor (Fig. l) , which was constant for samples of 500 g to 2000 g. Thus the composite SE for determining the "Cr content of the sample was k 0.7%. Similar values for SE were obtained by using photopeak radioactivity counts.
Immediately before sampling for the chemical determinations the homogenates were again vigorously mixed by means of a Silverson homogenizer to ensure an even suspension of the Cr,O,. About 5 g was then taken and boiled with 25 ml of concentrated nitric acid to destroy all organic matter. The digest was then boiled with 20 ml of concentrated perchloric acid to convert the chromium into the dichromate. (Pybus, 1969) . In calculating our results, 'recovery' was defined as marker outpudmarker intake for the period in question.
Results
In spite of the precautions taken to ensure regular stooling, the output of stool ranged from one-third to twice the amount expected. In Fig. 2, a comparison of the fractional recoveries of 51Cr and Cr,O, in the 49 collections is shown. It can be seen that good, but not complete, agreement was the rule. The mean recoveries for the 14 complete balance studies were 98.4% (SEM 2.1) for Cr,O, and 10 1.9% ( SEM 2.1) for WrCl,.
The two markers were further compared by determining which one minimized the variability in the daily faecal calcium output in the 12 studies performed under constant therapeutic regimens. Since no absolute calcium output rates were available, individual values for each collection period were compared with the mean of the three results for the study to which they belonged. The mean differences calculated in this way were, of course, zero, with SD values of 1.89 and 2.15 mmol of Ca/day for Cr,O, and 5'CrCI, respectively. These figures represent reductions in the variance of period to period calcium recoveries of 80-90%, since the equivalent figure for the uncorrected recoveries was 5.8 mmol of Ca/day. The variance ratio calculated from the two corrected figures was not statistically significant at the 5% level, so the differences between them may be due to chance. It was also observed that the individual deviations from the mean values as estimated by the two techniques were strongly correlated (r = 0.76, P < 0.001).
Only a small part of the differences between the paired values of the corrected recoveries can be attributed to known measurement errors. The SD of the fractional W r recovery as estimated from the Cr,O, recovery by the regression equation shown in Fig. 2 represents an uncertainty of 13% of the oral dose in any given period. The contribution to this 13% arising from measurement uncertainties and differences in the radioactivities contained within individual lCrC1, capsules together account for only a 2% uncertainty. Because Cr,O, minimizes the differences between serial stool calcium recoveries at least as well as WrCI,, the methodological uncertainties in the estimation of Cr,O, are unlikely to be any more significant as a source of imprecision.
Discussion
For many years Cr,O, has been used as an inert marker in balance studies (Whitby & Lang, 1960; Rose, 1964; Davignon, Simmonds & Ahrens, 1968) as an alternative to other non-radioactive markers (Soergel, 1968) .
L"Cr20,, produced by neutron activation of Cr,O, tablets, has been used as an inert marker for absorption of radioactive tracers (Ditchburn, Smith & Hayter, 1974) and for the measurements of gastrointestinal transit times (Hansky & Connell, 1962; Davignon et al., 1968; Bernier, 1969) . Various combinations of inert markers have been compared (Borgstrom, Dahlqvist, Lundh & Sjovall, 1957; Rose, 1964; Donaldson & Barreras, 1966; Soergel, 1968; Ditchburn et al., 1974) , but little information is available on the use of 51CrCI, as a continuous marker, although it has been found to be almost entirely unabsorbed from the gastrointestinal tracts of a variety of patients (Donaldson & Barreras, 1966) .
The present studies have shown that 51CrC1, behaves very similarly to Cr20, as a continuously administered faecal marker for the correction of faecal outputs in metabolic balance studies. In an 18-day calcium balance study with six duplicate diets and three 6day stool collections, we previously calculated that calcium intake is estimated with an uncertainty (SD) of 2.08/\/6 = 0.85 mmol of Ca/day (Reeve et al., 1976) . The overall uncertainty (SD) in an 18-day balance study is thus We conclude that there is little to choose between the two markers when the aim is to achieve accuracy and precision in a balance study. There appear to be small real differences between the transit patterns of the two markers, but these are insufficient to affect the choice between them, which thus depends principally on the convenience of estimation. The most commonly used technique for the determination of stable chromium in stools requires the prior oxidation of chromium to chromate with perchlorate. Because of the hazard of explosion of dry perchlorate salts, it is essential to handle this material in a designated fume cupboard with non-absorbent surfaces. Also great care is necessary to flush away drained material to avoid drying of significant amounts in the drainage system. Some investigators will therefore find it more convenient to use WrCI3. Those who have only the capacity to count small samples could, as an alternative to bulk sample counting, ash each whole sample and count the total ash (or a substantial portion thereof) in a well-type scintillation counter. A second option is to homogenize each stool sample and count a portion before measuring its calcium content.
